Skip to main content
;

HESA Committee Report

If you have any questions or comments regarding the accessibility of this publication, please contact us at accessible@parl.gc.ca.

PDF

APPENDIX A
LIST OF WITNESSES


Organizations and Individuals

Date

Meeting

Canadian Association for HIV Research

Bill Cameron, President

2010/04/13

8

PnuVax Inc.

Donald Gerson, President and Chief Executive Officer

   

Public Health Agency of Canada

Rainer Engelhardt, Assistant Deputy Minister,
Infectious Disease Prevention and Control Branch

   

Steven Sternthal, Head,
Canadian HIV Vaccine Initiative Secretariat, Director, Office of HIV Vaccines

   

Vaccine and Gene Therapy Institute Florida

Rafick-Pierre Sekaly, Co-Director and Scientific Director

   

Bill & Melinda Gates Foundation

Stefano Bertozzi, Director,
Global Health HIV

2010/04/15

9

Global HIV Vaccine Enterprise

Alan Bernstein, Executive Director

   

International Centre for Infectious Diseases

Heather Medwick, Acting President and Chief Executive Officer

   

International Consortium on Anti-Virals

Jeremy Carver, President,
Chief Executive Officer and Chief Scientific Officer

   

Patrick Michaud, Chairman of the Board of Directors

   

University of Manitoba

Keith Fowke, Professor,
Departments of Medical Microbiology and Community Health Sciences

   

University of Western Ontario

Ted Hewitt, Vice-President,
Research and International Relations

   

Public Health Agency of Canada

David Butler-Jones, Chief Public Health Officer

2010/04/22

11

Frank Plummer, Scientific Director General,
National Microbiology Laboratory

   

Public Health Agency of Canada

Steven Sternthal, Head,
Canadian HIV Vaccine Initiative Secretariat, Director, Office of HIV Vaccines

2010/04/22

11